MS Diet: Anti-Inflammatory Eating and What the Evidence Supports

Diet does not reverse multiple sclerosis or replace disease-modifying therapy (DMT), but the evidence supports anti-inflammatory eating as a meaningful add-on: Mediterranean-style patterns and correcting vitamin D deficiency are associated with lower disability scores, fewer relapses, and reduced fatigue. A 2023 cohort study of more than 6,900 MS patients found that higher Mediterranean diet adherence tracked with lower disability and better quality of life, and vitamin D research ties low serum levels to higher relapse rates and faster disease progression.

Why Diet Matters in MS

Multiple sclerosis is driven by immune dysregulation, not diet. Disease-modifying therapies (DMTs) remain the foundation of treatment. But the immune system does not operate in isolation. It responds to signals from the gut microbiome, metabolic status, and nutritional environment. Diet modulates all three [1].

The evidence is not strong enough to prescribe any specific diet as MS treatment. It is strong enough to say that what you eat influences disease activity, symptom severity, and quality of life alongside your DMT.

For background on how the underlying autoimmune process behind multiple sclerosis unfolds, and how disease-modifying therapies fit into a broader multiple sclerosis treatment plan, it helps to see dietary changes as a layer added on top of standard care rather than a substitute for it. Readers who want a wider view of how clinicians sequence DMTs, symptom management, and lifestyle changes can start with this overview of multiple sclerosis treatment options.

Vitamin D: The Strongest Nutritional Evidence

Vitamin D has the most robust evidence of any single nutrient in MS. The relationship operates at multiple levels [2]:

• Epidemiology: MS prevalence increases with latitude (less sun exposure = less vitamin D). Migration studies show that moving to a sunnier climate before age 15 reduces MS risk.
• Serum levels: Low vitamin D is a risk factor for developing MS and is associated with higher relapse rates, more MRI lesions, and faster disability progression.
• Mechanism: Vitamin D modulates T-cell function, promotes regulatory T cells, and suppresses Th17 cells (the same subset driving MS inflammation).
• Intervention: The SOLAR study and other trials showed that high-dose vitamin D supplementation (14,000 IU/day) reduced new MRI lesions when added to interferon-beta, though the effect on clinical relapses did not reach significance [3].

Current consensus among MS neurologists: maintain serum 25-OH vitamin D at 40-60 ng/mL (100-150 nmol/L). Most patients need 2,000-5,000 IU daily, with periodic blood level checks to adjust dosing.

The Gut-Brain Axis in MS

MS patients have distinct gut microbiome compositions compared to healthy controls. Key findings [4]:

• Reduced Prevotella species (associated with anti-inflammatory short-chain fatty acid production)
• Increased Akkermansia muciniphila (a mucin-degrading bacterium that may alter gut barrier function)
• Reduced overall diversity
• These shifts normalize somewhat with DMT treatment, suggesting the microbiome reflects disease activity

Diet is the primary modifiable factor shaping the gut microbiome. High-fiber diets promote beneficial bacteria and short-chain fatty acid (SCFA) production. SCFAs, particularly butyrate, promote regulatory T-cell differentiation and reduce neuroinflammation in animal models of MS [5].

Popular MS Diets: What the Evidence Says

The Swank Diet

Developed by neurologist Roy Swank starting in 1949, this is the oldest MS-specific diet. Core principles: limit saturated fat to under 15 g/day, supplement with cod liver oil, and eat fish several times per week.

Swank followed a cohort of 144 MS patients for 34 years. Those who adhered to the diet had significantly less disability and lower mortality than those who did not [6]. The study has methodological limitations (no randomization, no control group, self-selected adherence), but the magnitude and duration of follow-up make it notable.

A 2016 randomized pilot trial comparing the Swank diet to the Wahls Protocol found that both diets were associated with reduced fatigue at 12 months, but the study was underpowered to detect differences between them or compared to usual diet.

The Wahls Protocol

Developed by physician Terry Wahls, who has MS herself. The protocol is a modified Paleolithic diet emphasizing 9 cups of fruits and vegetables daily (3 cups leafy greens, 3 cups sulfur-rich vegetables, 3 cups deeply colored), grass-fed meat, organ meats, and elimination of grains, dairy, legumes, and refined sugar [7].

A 2018 pilot study showed that the Wahls Protocol reduced fatigue severity by 25% over 12 months, with improvements in walking speed and quality of life. A larger randomized trial is ongoing. The diet is nutrient-dense but restrictive, which affects adherence.

Mediterranean Diet

The Mediterranean pattern has the broadest evidence base for anti-inflammatory eating across autoimmune conditions. For MS specifically, a 2020 study of over 6,900 MS patients found that higher Mediterranean diet adherence was associated with lower disability, reduced depression scores, and better quality of life [8].

The Mediterranean diet is less restrictive than the Swank or Wahls diets, which improves long-term adherence. Key components: fatty fish, olive oil, vegetables, fruits, nuts, legumes, whole grains. Limited red meat, processed foods, and sugar.

Ketogenic Diet

Emerging interest based on theoretical neuroprotective mechanisms. Ketone bodies cross the blood-brain barrier and provide alternative fuel for neurons, which may help with MS-related fatigue and neurodegeneration. A small pilot study in RRMS patients showed improved fatigue and depression scores after 6 months on a ketogenic diet [9]. The diet is difficult to sustain and larger trials are needed.

Comparing the Swank, Wahls, Mediterranean, and Ketogenic Diets

Each of these patterns rests on a different core principle and a different type of evidence. The table below lines up what each diet asks of a patient against the strongest study behind it.

What to Eat: Evidence-Based Framework

Emphasize

• Fatty fish: 2-3 servings/week for omega-3 fatty acids. Salmon, sardines, mackerel, herring.
• Vegetables: 6-9 servings daily. Leafy greens (folate, nitrates), cruciferous vegetables (sulforaphane), and colorful produce (polyphenols).
• Fruits: 2-3 servings daily. Berries are particularly high in anthocyanins and flavonoids.
• Whole grains: Oats, quinoa, brown rice. Provide fiber for SCFA production.
• Olive oil: Primary cooking and dressing fat. Oleocanthal has anti-inflammatory properties comparable to low-dose ibuprofen.
• Nuts and seeds: Walnuts (omega-3), flaxseeds (lignans), almonds (vitamin E).
• Fermented foods: Yogurt, kefir, sauerkraut, kimchi for probiotic diversity.

Limit

• Saturated fat: Under 15-20 g/day (aligned with Swank recommendations). Reduce red meat, full-fat dairy, butter.
• Processed foods: Minimize ultra-processed items, fast food, and packaged snacks.
• Added sugar: Under 25 g/day. Excess sugar promotes systemic inflammation and adverse gut microbiome shifts.
• Sodium: High salt intake has been linked to increased MS disease activity in some studies [10], though the evidence is not fully consistent.
• Alcohol: Moderate or avoid. Alcohol has immunomodulatory effects and interacts with many MS medications.

Supplements Beyond Vitamin D

• Omega-3 fatty acids: 2-3 g EPA+DHA daily. Anti-inflammatory and neuroprotective. Evidence is mixed for MS relapse prevention but consistent for cardiovascular and mood benefits.
• Biotin (high-dose): 300 mg/day was studied in progressive MS (MD1003 trial). Initial results were promising for slowing disability, but a larger phase 3 trial failed to confirm benefit. Not currently recommended as standard treatment.
• Alpha-lipoic acid: 1,200 mg/day showed a reduction in brain atrophy rate in a 2-year pilot trial in secondary progressive MS. Further study is ongoing.
• Probiotics: A 2017 pilot RCT in MS patients showed that a multi-strain probiotic reduced inflammatory markers and improved depression and disability scores over 12 weeks.

Weight Management and MS

Obesity at any stage of MS is associated with worse outcomes:

• Childhood and adolescent obesity increases MS risk by 2x
• Obesity at diagnosis is associated with higher relapse rates
• Obesity accelerates disability progression independent of relapse rate
• Obesity reduces the efficacy of some DMTs

If you have MS and are overweight, achieving a healthy body weight through sustainable dietary changes and exercise is one of the most impactful modifiable factors within your control.

Because excess weight and fatigue often compound each other in MS, the related guide on multiple sclerosis and fatigue covers strategies that work alongside the dietary changes described here.

Intermittent Fasting and Caloric Restriction in MS

Caloric restriction and fasting-mimicking diets have been studied in animal models of MS, where they reduced disease severity and markers of inflammation by shifting immune cell populations toward a less inflammatory profile, according to Choi et al. (2016) [11]. A related small controlled pilot in people found signals of benefit on quality of life and inflammatory markers over a short fasting-mimicking cycle, though controlled data in MS patients remain limited.

Intermittent fasting is not currently recommended as a substitute for an established dietary pattern such as Mediterranean eating or the Wahls Protocol. It is best treated as an area of active research rather than a settled recommendation, and anyone considering it alongside a DMT should discuss timing and nutrition with their MS neurologist first.

Practical Implementation

1. Start with vitamin D: Get your level checked. Supplement to 40-60 ng/mL. Recheck in 3 months.
2. Increase fish and vegetables: These two changes alone shift the dietary pattern in a measurably anti-inflammatory direction.
3. Reduce processed food: Replace packaged snacks with nuts, fruit, and vegetables.
4. Choose your framework: Mediterranean (most sustainable for most people), Wahls (if willing to commit to Paleo-style restrictions), or Swank (if low-fat is easier for you to maintain).
5. Track and adjust: Keep a food and symptom diary for 3 months to identify personal patterns.
6. Work with your MS neurologist: Diet complements DMT. It does not replace it.
7. Loop in your broader care team: Clinics listed under multiple sclerosis treatment on Regenerated.com describe their own approach to DMT and symptom management, which can give you language to bring diet questions to your own neurologist or dietitian.

Frequently asked questions

Can diet reverse multiple sclerosis?

No. Diet does not reverse MS or replace disease-modifying therapy. The evidence supports anti-inflammatory eating, vitamin D correction, and weight management as additions to DMT that are associated with fewer relapses, lower disability scores, and reduced fatigue, not as a standalone treatment for the underlying autoimmune process.

What is the best diet for MS?

No single diet is established as best for everyone. The Mediterranean diet has the broadest evidence base and the easiest long-term adherence, while the Swank diet and Wahls Protocol are more restrictive but each has supporting studies, including Swank's 34-year cohort and Wahls's 2018 pilot showing a 25 percent fatigue reduction. The right choice often depends on which restrictions a person can sustain.

Should people with MS take vitamin D supplements?

Most MS neurologists recommend supplementation because low serum vitamin D is linked to higher relapse rates, more MRI lesions, and faster disability progression. Current guidance targets a 25-OH vitamin D level of 40 to 60 ng/mL, typically reached with 2,000 to 5,000 IU daily, with blood levels rechecked periodically to adjust the dose.

Does fasting help multiple sclerosis?

Early research is encouraging but limited. A fasting-mimicking diet reduced disease severity and inflammatory markers in animal models of MS and showed early signals of benefit in a small controlled human pilot, according to Choi et al. (2016). Larger trials are needed before intermittent fasting can be recommended as a standard part of MS care.

What foods should someone with MS avoid?

The clearest guidance is to limit saturated fat to under 15 to 20 grams daily, minimize ultra-processed foods and added sugar, and moderate sodium and alcohol intake. These limits are shared across the Swank diet, the Wahls Protocol, and Mediterranean-style eating, and align with the dietary pattern associated with lower disability in MS cohort studies.

Can losing weight improve MS symptoms?

Weight loss has not been shown in trials to directly reduce MS disability, but obesity is associated with worse outcomes at every stage, including higher relapse rates at diagnosis, faster disability progression, and reduced effectiveness of some disease-modifying therapies. Reaching a healthy weight through sustainable diet and exercise is one of the few modifiable factors patients can influence directly.

Related Reading

• Multiple Sclerosis: The Evidence-Based Guide (Pillar)
• Multiple Sclerosis Symptoms: Early Signs and Progression
• Multiple Sclerosis: A Complete Guide
• Multiple Sclerosis Treatment Options

Sources

1. Katz Sand I. The role of diet in multiple sclerosis: mechanistic connections and current evidence. Curr Nutr Rep. 2018;7(3):150-160. doi:10.1007/s13668-018-0236-z ↩
2. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832-2838. doi:10.1001/jama.296.23.2832 ↩
3. Hupperts R, Smolders J, Vieth R, et al. Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon beta-1a. Neurology. 2019;93(20):e1906-e1916. doi:10.1212/WNL.0000000000008445 ↩
4. Jangi S, Gandhi R, Cox LM, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7:12015. doi:10.1038/ncomms12015 ↩
5. Haghikia A, Jorg S, Duscha A, et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity. 2015;43(4):817-829. doi:10.1016/j.immuni.2015.09.007 ↩
6. Swank RL, Goodwin J. Review of MS patient survival on a Swank low saturated fat diet. Nutrition. 2003;19(2):161-162. doi:10.1016/S0899-9007(02)00851-1 ↩
7. Wahls TL, Chenard CA, Snetselaar LG. Review of two popular eating plans within the multiple sclerosis community: low saturated fat and modified paleolithic. Nutrients. 2019;11(2):352. doi:10.3390/nu11020352 ↩
8. Katz Sand I, Levy S, Engel B, et al. The Mediterranean diet is associated with reduced MS disability: results from a large observational cohort. Mult Scler. 2023;29(4):515-525. doi:10.1177/13524585231152714 ↩
9. Brenton JN, Banwell B, Bergqvist AGC, et al. Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2019;6(4):e565. doi:10.1212/NXI.0000000000000565 ↩
10. Farez MF, Fiol MP, Gaitan MI, et al. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(1):26-31. doi:10.1136/jnnp-2014-307928 ↩
11. Choi IY, Piccio L, Childress P, et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep. 2016;15(10):2136-2146. doi:10.1016/j.celrep.2016.05.009 ↩